Showing results (31-40 of 101) with videos related to

Sort By:
Pageof 11
BMC Nephrology|October 15, 2013
Tyrosine kinases inhibition by Imatinib slows progression in chronic anti-thy1 glomerulosclerosis of the ratYingrui Wang-Rosenke, Dymtro Khadzhynov, Tanja Loof, et al.
Journal of Clinical Pharmacology|October 22, 2005
FTY720, a novel immunomodulator in de novo kidney transplant patients: pharmacokinetics and exposure-response relationshipAndrej Skerjanec, Helio Tedesco, Hans-H Neumayer, et al.
Clinical Transplantation|November 15, 2006
FTY720 (fingolimod) in renal transplantationKlemens Budde, Manuela Schütz, Petra Glander, et al.
Transplant Immunology|December 26, 2007
Tabebuia avellanedae extracts inhibit IL-2-independent T-lymphocyte activation and proliferationTorsten Böhler, Jochen Nolting, Purevtseren Gurragchaa, et al.
Journal of Nephrology|December 1, 2006
Successful pregnancies in dialysis patients including those suffering from cystinosis and familial Mediterranean feverMichael Haase, Stanislao Morgera, Christian Bamberg, et al.
Kidney International|July 9, 2003
NO mediates antifibrotic actions of L-arginine supplementation following induction of anti-thy1 glomerulonephritisHarm Peters, Ute Daig, Sebastian Martini, et al.
Journal of Cardiovascular Pharmacology|April 20, 2005
Inhibition of both neutral endopeptidase and endothelin-converting enzyme by SLV306 reduces proteinuria and urinary albumin excretion in diabetic ratsChrista Thöne-Reinke, Katja Simon, Claus-Michael Richter, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 20, 2011
Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejectionJohannes Waiser, Klemens Budde, Manuela Schütz, et al.
Pageof 11